Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma

E-ISSN： 1873-5576|17|2|137-157

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.2, 2017-01, pp. : 137-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticancer Immunotherapy in Combination with Proapoptotic Therapy

Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. : 666-675

Bentham Science Publishers

Access to resources Recommend Favorite

Combination therapy superior for treatment of onychomycosis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 341, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Combination Therapy

By O»Connor B.J.

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 5, 1998-10 ,pp. : 397-399

Academic Press

Access to resources Recommend Favorite

Alpha-Emitters for Immuno-Therapy: A Review of Recent Developments from Chemistry to Clinics

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 23, 2012-01 ,pp. : 2642-2654

Bentham Science Publishers

Access to resources Recommend Favorite

Fenofibric Acid: In Combination Therapy in the Treatment of Mixed Dyslipidemia

By Yang Lily P.H. Keating Gillian M.

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 6, 2009-12 ,pp. : 401-409

Adis International

Access to resources Recommend Favorite